A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

Status:
Completed

Trial end date:
2019-07-29

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the efficacy and safety of molidustat in peritoneal dialysis subjects with renal anemia

Phase 3

Bayer